Name | Number of supported studies | Average coverage | |
---|---|---|---|
type I pneumocyte | 12 studies | 48% ± 15% | |
astrocyte | 12 studies | 34% ± 16% | |
basal cell | 7 studies | 30% ± 17% | |
microglial cell | 7 studies | 36% ± 12% | |
retinal bipolar neuron | 4 studies | 31% ± 22% | |
club cell | 3 studies | 32% ± 10% | |
rod bipolar cell | 3 studies | 54% ± 18% | |
oligodendrocyte precursor cell | 3 studies | 22% ± 7% | |
alveolar macrophage | 3 studies | 21% ± 4% | |
interneuron | 3 studies | 19% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 1257.72 | 652 / 653 | 95% | 25.80 | 576 / 605 |
brain | 88% | 1242.27 | 2333 / 2642 | 98% | 49.25 | 692 / 705 |
lung | 99% | 2481.11 | 575 / 578 | 75% | 13.19 | 871 / 1155 |
breast | 89% | 457.15 | 409 / 459 | 82% | 15.62 | 916 / 1118 |
prostate | 87% | 853.58 | 214 / 245 | 81% | 8.84 | 408 / 502 |
muscle | 100% | 1573.23 | 799 / 803 | 0% | 0 | 0 / 0 |
esophagus | 49% | 160.52 | 711 / 1445 | 50% | 6.42 | 92 / 183 |
blood vessel | 95% | 1111.07 | 1272 / 1335 | 0% | 0 | 0 / 0 |
adipose | 87% | 535.12 | 1048 / 1204 | 0% | 0 | 0 / 0 |
heart | 83% | 447.22 | 712 / 861 | 0% | 0 | 0 / 0 |
ovary | 24% | 75.08 | 43 / 180 | 55% | 6.30 | 236 / 430 |
skin | 59% | 274.48 | 1071 / 1809 | 16% | 1.97 | 77 / 472 |
stomach | 14% | 38.03 | 49 / 359 | 50% | 5.10 | 144 / 286 |
uterus | 16% | 57.34 | 27 / 170 | 45% | 6.47 | 208 / 459 |
adrenal gland | 24% | 107.10 | 63 / 258 | 36% | 7.52 | 83 / 230 |
tonsil | 0% | 0 | 0 / 0 | 51% | 5.49 | 23 / 45 |
intestine | 12% | 32.01 | 112 / 966 | 36% | 3.44 | 192 / 527 |
pancreas | 1% | 1.46 | 2 / 328 | 44% | 3.68 | 79 / 178 |
kidney | 8% | 16.17 | 7 / 89 | 37% | 2.84 | 329 / 901 |
bladder | 5% | 8.67 | 1 / 21 | 27% | 3.15 | 137 / 504 |
lymph node | 0% | 0 | 0 / 0 | 17% | 0.99 | 5 / 29 |
eye | 0% | 0 | 0 / 0 | 6% | 0.38 | 5 / 80 |
peripheral blood | 6% | 16.77 | 55 / 929 | 0% | 0 | 0 / 0 |
spleen | 5% | 13.73 | 13 / 241 | 0% | 0 | 0 / 0 |
liver | 1% | 1.71 | 2 / 226 | 4% | 0.32 | 17 / 406 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0030182 | Biological process | neuron differentiation |
GO_0006935 | Biological process | chemotaxis |
GO_0007155 | Biological process | cell adhesion |
GO_0007411 | Biological process | axon guidance |
GO_0005615 | Cellular component | extracellular space |
GO_0009986 | Cellular component | cell surface |
GO_0005576 | Cellular component | extracellular region |
GO_0005886 | Cellular component | plasma membrane |
GO_0031012 | Cellular component | extracellular matrix |
GO_0005201 | Molecular function | extracellular matrix structural constituent |
GO_0008201 | Molecular function | heparin binding |
GO_0004867 | Molecular function | serine-type endopeptidase inhibitor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | ANOS1 |
Protein name | Anosmin-1 (Adhesion molecule-like X-linked) (Kallmann syndrome protein) Anosmin-1 (EC 3.4.21.4) |
Synonyms | ADMLX KAL KAL1 KALIG1 |
Description | FUNCTION: Has a dual branch-promoting and guidance activity, which may play an important role in the patterning of mitral and tufted cell collaterals to the olfactory cortex (By similarity). Chemoattractant for fetal olfactory epithelial cells. . |
Accessions | ENST00000262648.8 P23352 A0A1B0RPQ5 |